Project Grant R01AI197146
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $822,015 Project Grant titled "NOVEL STATISTICAL METHODS FOR CONFOUNDED AND INCOMPLETE NETWORK DATA" to the University of Pennsylvania. This grant, provided under the NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of new statistical methodologies to address challenges posed by missing data, confounding, and complex social network structures in studies of public...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of new Bayesian causal structural discovery and reinforcement learning methods to investigate the effects of combination antiretroviral therapy (cART) regimens on viral suppression and depression outcomes for people living with HIV. The $145,299 award to The Johns Hopkins University will leverage...
- The federal Project Grant award for "PHYLOGENETICS, CAUSAL INFERENCE, AND MODEL DIAGNOSTICS FOR LONGITUDINAL STUDIES OF INFECTIOUS DISEASE TRANSMISSION AND CONTROL" was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The $537,861 award will support research to extend statistical methods for studying disease transmission in households and other close contact groups....
- This $137,064 federal Project Grant was awarded on July 25, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant will fund a 2-year study at the University of Florida to develop new system science models for dynamically measuring and validating people's accessibility to healthcare services. The research aims to address limitations in current static, population-based approaches by...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $489,500 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to The Children's Hospital Corporation (doing business as Boston Children's Hospital) on July 24, 2025. The grant will fund structural studies of the full-length nucleocapsid (N) protein of SARS-CoV-2, the virus that causes COVID-19. The goal is to determine the high-resolution structure of the full-length N protein in complex...
- This $420,553 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to develop a single-cell technique that will measure the translation rate and transcriptome of thousands of individual bacterial cells, with a focus on understanding antibiotic tolerance in Staphylococcus aureus during chronic infections. The research will explore the heterogeneity in...
- This $481,250 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant will fund the development of new antimicrobial small molecule compounds that recruit the immune system to target bacteria. Key activities include the biochemical, biophysical, and cell biology characterization of these chimeric molecules formed by joining bacterial binding agents with...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $721,721 to the University of California, Los Angeles (UCLA) to establish the UCLA RAPID, RIGOROUS, RELEVANT IMPLEMENTATION SCIENCE HUB. This five-year grant, running from August 1, 2025 to July 31, 2030, will leverage implementation science to enhance the translation of HIV research into routine clinical practice and improve population health outcomes. Key objectives include providing technical...
- This $160,546 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports research towards developing a novel spatiotemporal machine learning framework for epidemic models of respiratory infections. The award to Emory University in Atlanta, Georgia, with a period of performance from September 3, 2025 through August 31, 2029, aims to advance foundational epidemiological...
- This $193,375 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify bacterial determinants that may contribute to variable treatment responses for tuberculosis (TB). The project, conducted by researchers at the Harvard T.H. Chan School of Public Health, aims to investigate the effects of clinically prevalent variants in the ESX1 secretion system on TB...
This $250,000 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Program (CFDA 93.855), will support the development of a structural causal framework for adaptive randomized clinical trials in infectious disease research. The project aims to address key methodological challenges in adaptive trials, such as unclear inferential targets, statistical biases from temporal and spatial variability, complex data structures, and the risk of false-positive findings. The researchers at New York University will leverage secondary data from the Adaptive COVID-19 Treatment Trial (ACTT) to enable transparent, efficient, and statistically unbiased estimation of causal effects in adaptive trials. The project's specific aims include developing causal approaches to handle temporal and spatial variability, as well as expanding the framework to address complex data structures and false-positive results. This research aligns with NIAID's mission to advance methodologies for infectious disease clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/21/25 | ||
| Not listed | $250.0k | 8/6/25 |